Pārskats
Akcijas cenas izmaiņa
24h
Šī brīža
Min
7.48
Max
7.97
Rekomendācijas | Pārdot |
|---|---|
Prognoze 12 mēnešiem | -10.71% downside |
Nākamie ieņēmumi | 2026. g. 5. nov. |
|---|
Ziņu noskaņojums
By Acuity
50%
50%
125 / 339 Rangs Healthcare
Ginkgo Bioworks Holdings Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Saistītās ziņas
2026. g. 17. sept. 20:02 UTC
Ginkgo Bioworks shares rise sharply amid notable call options trading, supported by gains in the ARK Genomic Revolution ETF, despite an earlier pullback.
Lasīt
2026. g. 16. sept. 19:26 UTC
Ginkgo Bioworks announced a partnership with Eli Lilly's TuneLab to enhance drug development efficiency, as shares fell slightly since Tuesday's close.
Lasīt
2026. g. 15. sept. 20:07 UTC
Ginkgo Bioworks shares are lower, reflecting broader market declines amid negative economic indicators and rising oil prices. Earlier, shares briefly rebounded before pulling back.
Lasīt
2026. g. 14. sept. 23:06 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market hours. The broader market faces pressure from rising crude oil prices amid supply concerns.
Lasīt
2026. g. 2. sept. 19:56 UTC
Ginkgo Bioworks is gaining traction amid social media discussions on Pfizer and Google announcements, despite a generally negative market environment.
Lasīt
2026. g. 1. sept. 23:06 UTC
Ginkgo Bioworks shares are higher in after-market trading, reaching a peak above the previous day's close. The stock remains below its 20-day moving average.
Lasīt
2026. g. 31. aug. 22:16 UTC
Ginkgo Bioworks Holdings Inc is trading higher in after-market hours, influenced by broader market reactions to comments on inflation and interest rate expectations.
Lasīt
2026. g. 28. aug. 22:02 UTC
Ginkgo Bioworks Holdings Inc shares are higher in after-market trading, continuing a recent trend of daily gains despite no specific news to explain the move.
Lasīt
2026. g. 26. aug. 20:08 UTC
Ginkgo Bioworks Holdings Inc is lower today, influenced by declines in the Life Sciences Tools & Services sub-sector and trading below its 20-day moving average.
Lasīt
2026. g. 25. aug. 20:07 UTC
Ginkgo Bioworks shares advance amid positive sentiment linked to Moderna and Merck. Earlier, shares pulled back from a session high but gained traction.
Lasīt
2026. g. 24. aug. 20:02 UTC
Ginkgo Bioworks shares are lower today amid broader market volatility and geopolitical concerns, with no specific company news identified to explain the decline.
Lasīt
2026. g. 21. aug. 23:56 UTC
Ginkgo Bioworks Holdings Inc is higher in after-market trading amid a broader market rebound, despite no specific company news identified.
Lasīt
2026. g. 20. aug. 23:41 UTC
Ginkgo Bioworks Holdings Inc. gained in after-market trading, supported by broader market movements and positive jobless claims data. Shares remain below their 20-day moving average.
Lasīt
2026. g. 19. aug. 23:51 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market trading. The stock is also below its 20-day moving average.
Lasīt
2026. g. 17. aug. 19:46 UTC
Ginkgo Bioworks is advancing amid positive market sentiment following a rise in New York manufacturing conditions. Shares pulled back slightly after reaching a session high.
Lasīt
2026. g. 14. aug. 19:46 UTC
Ginkgo Bioworks Holdings Inc shares are lower amid broader market declines following a surprising drop in U.S. retail sales for July.
Lasīt
2026. g. 11. aug. 20:02 UTC
Ginkgo Bioworks shares are lower, tracking the broader market's decline. The stock remains below its 20-day moving average after four consecutive sessions of losses.
Lasīt
2026. g. 10. aug. 19:26 UTC
Ginkgo Bioworks reported second-quarter revenue of $20 million, a 48% decline year-over-year. Shares are trading lower, extending a three-day decline.
Lasīt
2026. g. 7. aug. 22:26 UTC
Ginkgo Bioworks shares decline in after-market hours following TD Cowen's downgrade to Hold and a price target cut to $9.
Lasīt
2026. g. 6. aug. 20:02 UTC
Ginkgo Bioworks is down significantly today, continuing a decline since Wednesday's close, despite recent operational improvements and a brief recovery earlier in the session.
Lasīt
2026. g. 5. aug. 22:51 UTC
Ginkgo Bioworks shares are lower in after-market trading following a revenue miss of $20 million, despite an EPS beat of -$0.92.
Lasīt
2026. g. 4. aug. 19:46 UTC
Ginkgo Bioworks shares are higher today, continuing a four-session rally, supported by broader market trends and easing inflation concerns from falling crude oil prices.
Lasīt
2026. g. 3. aug. 20:04 UTC
Ginkgo Bioworks Holdings Inc. is up notably since Friday's close, reflecting strong performance amid broader market gains, despite a slight pullback earlier in the session.
Lasīt
2026. g. 31. jūl. 23:16 UTC
Ginkgo Bioworks shares are lower in after-market hours, reflecting broader market weakness and challenges in the specialty chemicals sector.
Lasīt
2026. g. 29. jūl. 19:47 UTC
Ginkgo Bioworks has signed a $2.3 million deal with Thermo Fisher for 11 chips. Shares are declining amid broader market weakness and economic uncertainties.
Lasīt
2026. g. 28. jūl. 22:46 UTC
Ginkgo Bioworks Holdings Inc. shares are lower in after-market hours, continuing a downward trend amid broader market weakness ahead of the Federal Reserve's policy meeting.
Lasīt
2026. g. 27. jūl. 20:51 UTC
Ginkgo Bioworks shares are higher in after-market hours, supported by broader market trends as European indices, including the DAX, also rise.
Lasīt
2026. g. 24. jūl. 19:07 UTC
Ginkgo Bioworks participates in the $400 million Genesis Mission but shares are lower amid broader market declines influenced by falling crude oil prices.
Lasīt
2026. g. 21. jūl. 17:36 UTC
Ginkgo Bioworks Holdings Inc. is higher today, recovering from a session low, and has gained since Monday amid a broader market uptrend.
Lasīt
Salīdzinājums
Cenas izmaiņa
Ginkgo Bioworks Holdings Inc Prognoze
Cenas mērķis
By TipRanks
Prognoze 12 mēnešiem
Vidējais 7 USD -10.71%
Augstākais 9 USD
Zemākais 5 USD
Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Ginkgo Bioworks Holdings Inc — pēdējo 3 mēnešu laikā.
Vērtējuma vienprātība
By TipRanks
Pārdot
3 ratings
0
Pirkt
1
Turēt
2
Pārdot
Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Ginkgo Bioworks Holdings Inc — pēdējo 3 mēnešu laikā.
Noskaņojums
By Acuity
Ziņu noskaņojums
Neutral
Volatilitāte
Zem vidējā
Ziņu apjoms (RCV)
Vidējais
Finanšu rādītāji
$